Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$8.48 - $12.23 $82,603 - $119,132
-9,741 Closed
0 $0
Q3 2020

Jun 26, 2023

BUY
$9.99 - $14.41 $97,312 - $140,367
9,741 New
9,741 $106,000
Q2 2020

May 24, 2024

BUY
$12.28 - $17.63 $119,619 - $171,733
9,741 New
9,741 $134 Million
Q2 2020

Jun 26, 2023

BUY
$12.28 - $17.63 $119,619 - $171,733
9,741 New
9,741 $134,000
Q1 2020

Jul 12, 2023

BUY
$11.31 - $18.26 $110,170 - $177,870
9,741 New
9,741 $129,000
Q1 2020

Mar 22, 2023

BUY
$11.31 - $18.26 $110,170 - $177,870
9,741 New
9,741 $129,000
Q1 2020

May 15, 2020

BUY
$11.31 - $18.26 $110,170 - $177,870
9,741 New
9,741 $129,000

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.